Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


WENTWORTH KORY JAMES Create: Alert

All | News | Filings
Date FiledTypeDescription
07/12/2023 4 WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 6,116 shares @ $17.9788, valued at $110k
Sold 3,884 shares @ $17.9979, valued at $69.9k
Exercised 6,116 options to buy @ $2.1, valued at $12.8k
Exercised 3,884 options to buy @ $2.1, valued at $8.2k
06/30/2023 4 WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Exercised 8,790 options to buy @ $2.1, valued at $18.5k
04/19/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
12/12/2022 4 WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 4,550 shares @ $18.9534, valued at $86.2k
Exercised 4,550 options to buy @ $2.1, valued at $9.6k
12/06/2022 4 WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 2,910 shares @ $18.1957, valued at $52.9k
Sold 200 shares @ $18.05, valued at $3.6k
Exercised 2,910 options to buy @ $2.1, valued at $6.1k
Exercised 200 options to buy @ $2.1, valued at $420
11/18/2022 4 WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 200 shares @ $18.1, valued at $3.6k
Exercised 200 options to buy @ $2.1, valued at $420
09/06/2022 4 WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Granted 5,503 shares @ $0
08/26/2022 4 WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 2,817 shares @ $13.5226, valued at $38.1k
Sold 301 shares @ $14.227, valued at $4.3k
Sold 1,551 shares @ $14.1754, valued at $22k
Exercised 1,117 options to buy @ $2.1, valued at $2.3k
08/23/2022 4 WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 8,529 shares @ $13.0766, valued at $111.5k
Sold 217 shares @ $13.0047, valued at $2.8k
Sold 2,909 shares @ $13.0903, valued at $38.1k
Exercised 4,452 options to buy @ $2.1, valued at $9.3k
Exercised 117 options to buy @ $2.1, valued at $245.7
Exercised 1,403 options to buy @ $2.1, valued at $2.9k
08/18/2022 4 WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 200 shares @ $13, valued at $2.6k
Sold 200 shares @ $13.07, valued at $2.6k
Sold 200 shares @ $13, valued at $2.6k
Exercised 100 options to buy @ $2.1, valued at $210
Exercised 100 options to buy @ $2.1, valued at $210
Exercised 100 options to buy @ $2.1, valued at $210
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/01/2021 4 WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Granted 72,012 options to buy @ $20, valued at $1.4M
10/28/2021 3 WENTWORTH KORY JAMES (CFO) has filed a Form 3 on Entrada Therapeutics, Inc.
07/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2020 4 WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.
Txns: Sold 92 shares @ $65.0065, valued at $6k
Sold 62 shares @ $65.5616, valued at $4.1k
03/04/2020 4 WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.
Txns: Granted 3,900 shares @ $0
Granted 7,800 options to buy @ $73.84, valued at $576k
01/09/2020 4 WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.
Txns: Sold 223 shares @ $89.9712, valued at $20.1k
12/23/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2019 4 WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.
Txns: Sold 27 shares @ $126.1135, valued at $3.4k
Sold 17 shares @ $127.2524, valued at $2.2k
Sold 8 shares @ $129.5113, valued at $1k
Sold 9 shares @ $131.0456, valued at $1.2k
06/05/2019 4 WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.
Txns: Granted 212 shares @ $0
03/04/2019 4 WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.
Txns: Sold 51 shares @ $151.71, valued at $7.7k
02/27/2019 4 WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.
Txns: Sold 208 shares @ $150.0038, valued at $31.2k
02/05/2019 4 WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.
Txns: Granted 2,500 shares @ $0
Granted 10,000 options to buy @ $134.63, valued at $1.3M
01/30/2019 4 WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.
Txns: Sold 209 shares @ $125.964, valued at $26.3k
12/21/2018 4 WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.
Txns: Sold 388 shares @ $103.05, valued at $40k
01/04/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/20/2017 3 WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 3 on bluebird bio, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy